Search

Your search keyword '"Lauren C Harshman"' showing total 12 results
Start Over Author "Lauren C Harshman" Journal annals of oncology
12 results on '"Lauren C Harshman"'

1. 681P Clinical and immune responses to immunotherapy in biochemically recurrent (non-metastatic castration sensitive) prostate cancer (BCRpc)

Author

Myrna Rauckhorst, Renee N. Donahue, Lisa M. Cordes, Marijo Bilusic, Fatima Karzai, N. Williams, J. Schlom, William L. Dahut, Anna Couvillon, Susan Wroblewski, Xiao X. Wei, Amy Hankin, Philip W. Kantoff, James L. Gulley, Philip M. Arlen, Nicole Toney, Ravi A. Madan, Susan F. Slovin, Julius Strauss, and Lauren C. Harshman

Subjects
Immune system, Oncology, business.industry, medicine.medical_treatment, medicine, Cancer research, Non metastatic, Hematology, Immunotherapy, business, Castration-sensitive prostate cancer
Published
2020
Full Text
View/download PDF

2. Outcomes of patients with metastatic urothelial carcinoma (mUC) with exclusive bone metastases: Focus on a special patient population

Author

Ali Reza Golshayan, Elizabeth R. Plimack, Jonathan E. Rosenberg, Joaquim Bellmunt, Sylvain Ladoire, Lauren C. Harshman, Aristotle Bamias, Simon J. Crabb, Guenter Niegisch, Sumanta K. Pal, Evan Y. Yu, Thomas Powles, Matthew D. Galsky, Andrea Necchi, Daniel W. Bowles, Srikala S. Sridhar, Dominik Berthold, Greg Pond, Jack Baniel, and Neeraj Agarwal

Subjects
Oncology, medicine.medical_specialty, Patient population, Focus (computing), Metastatic Urothelial Carcinoma, business.industry, Internal medicine, medicine, Hematology, business
Published
2017
Full Text
View/download PDF

3. First interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza)

Author

Jan Kalinovsky, John P Logue, Marcello Tucci, R Concepcion, S. Sundar, P. Borrega, John Sylvester, Lauren C. Harshman, D. Schrijvers, Bertrand Tombal, Oliver Sartor, P Ziem, Y. De Sanctis, Constantine Mantz, Cora N. Sternberg, Saby George, Martin Schostak, and Kurt Miller

Subjects
Radium-223, Oncology, medicine.medical_specialty, business.industry, 030232 urology & nephrology, Hematology, 03 medical and health sciences, Abiraterone, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Interim, Internal medicine, medicine, Enzalutamide, Observational study, business, medicine.drug
Published
2017
Full Text
View/download PDF

4. Change in neutrophil-to-lymphocyte ratio (NLR) in response to immunotherapy for metastatic renal cell carcinoma (mRCC)

Author

A-K A Lalani, Dominick Bossé, Bradley Alexander McGregor, Dylan J. Martini, Craig Norton, Joaquim Bellmunt, T.K. Choueiri, Lauren C. Harshman, John A. Steinharter, E.M. Van Allen, and Wanling Xie

Subjects
Oncology, Renal cell carcinoma, business.industry, medicine.medical_treatment, Cancer research, medicine, Hematology, Immunotherapy, Neutrophil to lymphocyte ratio, medicine.disease, business
Published
2017
Full Text
View/download PDF

5. Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC)

Author

Pier Vitale Nuzzo, Lauren C. Harshman, Dylan J. Martini, Bradley Alexander McGregor, Toni K. Choueiri, John A. Steinharter, A.-K. Lalani, N. Martinez Chanza, Wanling Xie, and Mehmet Asim Bilen

Subjects
biology, Cabozantinib, business.industry, 030232 urology & nephrology, Hematology, medicine.disease, Immune checkpoint, Blockade, 03 medical and health sciences, chemistry.chemical_compound, Clear cell renal cell carcinoma, 0302 clinical medicine, Oncology, chemistry, 030220 oncology & carcinogenesis, PD-L1, biology.protein, medicine, Cancer research, business
Published
2018
Full Text
View/download PDF

6. Pharmacokinetic (PK) analysis of concurrent administration of enzalutamide (enza) and crizotinib (crizo) in patients with metastatic castration resistant prostate cancer (CRPC)

Author

Z. Melnick, M. Taplin, Joaquim Bellmunt, S. Srinivas, Mark Pomerantz, Jeffrey G. Supko, P.W. Kantoff, Atish D. Choudhury, Lauren C. Harshman, Christopher Sweeney, Kathryn P. Gray, C. Yu, Abhishek Tripathi, and Zijie Sun

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, Crizotinib, business.industry, Hematology, Castration resistant, medicine.disease, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 030104 developmental biology, Pharmacokinetics, chemistry, Internal medicine, medicine, Enzalutamide, In patient, business, medicine.drug
Published
2018
Full Text
View/download PDF

7. Impact of cisplatin-based therapy on long-term survival in advanced urinary tract cancer (aUTC). A retrospective international study of invasive/advanced cancer of the urothelium (RISC)

Author

Evan Y. Yu, Lauren C. Harshman, Christina Bamia, Simon J. Crabb, Matthew D. Galsky, Sumanta K. Pal, Thomas Powles, Neeraj Agarwal, Kimon Tzannis, Andrea Necchi, Y.-N. Wong, Jonathan E. Rosenberg, Cora N. Sternberg, Joaquim Bellmunt, Ulka N. Vaishampayan, Guenter Niegisch, Sylvain Ladoire, Aristotle Bamias, U. De Giorgi, and A. Srinivas

Subjects
0301 basic medicine, Cisplatin, Oncology, medicine.medical_specialty, business.industry, Urinary system, Urology, Cancer, Hematology, medicine.disease, Advanced cancer, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Long term survival, medicine, Urothelium, business, medicine.drug
Published
2017
Full Text
View/download PDF

8. Pazopanib (p) or sorafenib (s) + radium-223 (rad) in metastatic renal cell carcinoma (mrcc) with bone metastases (bm)

Author

Toni K. Choueiri, Meghara K. Walsh, Kathryn P. Gray, Heather A. Jacene, Mark Pomerantz, Rana R. McKay, Dominick Bossé, M.D. Michaelson, Lauren C. Harshman, Joaquim Bellmunt, Katherine M. Krajewski, and C. Sleeper

Subjects
0301 basic medicine, Oncology, Sorafenib, Radium-223, medicine.medical_specialty, business.industry, Hematology, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Renal cell carcinoma, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, medicine.drug
Published
2017
Full Text
View/download PDF

9. Nomogram-based prediction of overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (UC) receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC)

Author

Matthew D. Galsky, Y.-N. Wong, Ulka N. Vaishampayan, Joaquim Bellmunt, Lauren C. Harshman, Cora N. Sternberg, Simon J. Crabb, Sylvain Ladoire, Aristotle Bamias, Jonathan E. Rosenberg, G. Sonpavde, U. De Giorgi, S. Lo Vullo, Andrea Necchi, Luigi Mariani, Sandy Srinivas, Simon Chowdhury, Guenter Niegisch, Evan Y. Yu, and Sumanta K. Pal

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, Metastatic Urothelial Carcinoma, business.industry, medicine.medical_treatment, First line, Urology, Hematology, Nomogram, Advanced cancer, Internal medicine, medicine, Overall survival, Urothelium, business
Published
2016
Full Text
View/download PDF

10. Patterns of chemotherapy utilization in metastatic urothelial cancer (mUC): analysis from the retrospective international study of invasive/advanced cancer of the urothelium (RISC) database

Author

Ajjai Alva, Jonathan E. Rosenberg, M. Liontos, U. De Giorgi, Evan Y. Yu, Neeraj Agarwal, Lauren C. Harshman, Y.-N. Wong, Simon J. Crabb, Cora N. Sternberg, Guenter Niegisch, Joaquim Bellmunt, Sandhya Srinivas, Sylvain Ladoire, Aristotle Bamias, Risc Investigators, Sumanta K. Pal, Thomas Powles, and Kimon Tzannis

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Hematology, 030204 cardiovascular system & hematology, Advanced cancer, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Medicine, Urothelial cancer, 030212 general & internal medicine, Urothelium, business
Published
2016
Full Text
View/download PDF

11. Everolimus / pazopanib (E/P) benefits genomically selected patients (pts) with metastatic urothelial carcinoma (mUC)

Author

Stephanie A. Mullane, P.W. Kantoff, Lauren C. Harshman, Susanna Jacobus, E.M. Van Allen, Laura Polacek, Joaquim Bellmunt, David Y. Takeda, Jonathan E. Rosenberg, Nikhil Wagle, and Toni K. Choueiri

Subjects
Oncology, Pazopanib, medicine.medical_specialty, Everolimus, Metastatic Urothelial Carcinoma, business.industry, Internal medicine, Medicine, Hematology, business, medicine.drug
Published
2016
Full Text
View/download PDF

12. Adherence to cisplatin-based regimens prescription in 'fit' patients fulfilling platinum eligibility criteria. Impact on outcomes: a retrospective international study of invasive/advanced cancer of the urothelium (RISC) analysis

Author

Ulka N. Vaishampayan, Neeraj Agarwal, Guenter Niegisch, Lauren C. Harshman, Jonathan E. Rosenberg, Simon J. Crabb, U. De Giorgi, M. Liontos, Risc Investigators, Y.-N. Wong, Joaquim Bellmunt, Sylvain Ladoire, Aristotle Bamias, Kimon Tzannis, Andrea Necchi, Evan Y. Yu, Sumanta K. Pal, Thomas Powles, and Cora N. Sternberg

Subjects
Oncology, Cisplatin, medicine.medical_specialty, business.industry, Hematology, 030204 cardiovascular system & hematology, Advanced cancer, Surgery, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, 030212 general & internal medicine, Urothelium, Medical prescription, business, medicine.drug
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results